Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model
Open Access
- 24 December 2020
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 37 (1) , 27-36
Abstract
Diabetes is associated with progression to severe COVID-19. The objective of this study was to estimate to what extent the increased risk among people with diabetes could impact the secondary care ...Keywords
This publication has 27 references indexed in Scilit:
- Response to COVID-19 in TaiwanJAMA, 2020
- Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort StudyDiabetes Care, 2018
- The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)Diabetes Care, 2018
- Economic Costs of Diabetes in the U.S. in 2017Diabetes Care, 2018
- Comparison of Glycemic Control Between Continuous Regular Insulin Infusion and Single-Dose Subcutaneous Insulin Glargine Injection in Medical Critically Ill PatientsIndian Journal of Critical Care Medicine, 2018
- The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of ComplicationsPLOS ONE, 2016
- Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparisonDiabetic Medicine, 2014
- Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA studyClinical Endocrinology, 2012
- Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of TherapyCritical Care Nursing Quarterly, 2004
- Immune dysfunction in patients with diabetes mellitus (DM)FEMS Immunology & Medical Microbiology, 1999